Novel polymer monolith microextraction using a poly(methacrylic acid-ethylene glycol dimethacrylate) monolith and its application to simultaneous analysis of several angiotensin II receptor antagonists in human urine by capillary zone electrophoresis.
Novel polymer monolith microextraction (PMME) using a poly(methacrylic acid-ethylene glycol dimethacrylate) (poly(MAA-EGDMA)) monolith in conjunction with capillary zone electrophoresis (CZE) was developed for the determination of several angiotensin II receptor antagonists (ARA-IIs) in human urine. The extraction device consisted of a regular plastic syringe (1 mL), a poly(MAA-EGDMA) monolithic capillary (2 cm x 530 microm I.D.) and a plastic pinhead connecting the former two components seamlessly. The extraction was achieved by driving the sample solution through the monolithic capillary tube using a syringe infusion pump, and for the desorption step, an aliquot of organic solvent was injected via the monolithic capillary and collected into a vial for subsequent analysis by CZE. The best separation was realized at 25 kV using a buffer that consisted of 50% acetonitrile and 50% buffer solution (v/v) containing 10 mM disodium hydrogenphosphate (adjusted to pH 2.3 with 1M hydrochloric acid). The method was successfully applied to the determination of telmisartan (T), irbesartan (I) and losartan (L) in urine samples with candesartan (C) as internal standard, yielding the detection limit of 15-20 ng/mL. Close correlation coefficients (R>0.999) and excellent method reproducibility were obtained for all the analytes over a linear range of 0.08-3 microg/mL.
Zhang
Min
M
Department of Chemistry, Wuhan University, Wuhan 430072, China.
Wei
Fang
F
Zhang
Yi-Fei
YF
Nie
Jing
J
Feng
Yu-Qi
YQ
D000804:Angiotensin II / Q000378:metabolism*; D057911:Angiotensin Receptor Antagonists; D001562:Benzimidazoles / Q000652:urine*; D001565:Benzoates / Q000652:urine*; D001713:Biphenyl Compounds / Q000652:urine*; D019075:Electrophoresis, Capillary / Q000379:methods*; D005026:Ethylene Glycols / Q000737:chemistry*; D006801:Humans; D000077405:Irbesartan; D019808:Losartan / Q000652:urine*; D008689:Methacrylates / Q000737:chemistry*; D011945:Receptors, Angiotensin / Q000378:metabolism; D012680:Sensitivity and Specificity; D000077333:Telmisartan; D013777:Tetrazoles / Q000652:urine*
D057911:Angiotensin Receptor Antagonists; D001562:Benzimidazoles; D001565:Benzoates; D001713:Biphenyl Compounds; D005026:Ethylene Glycols; D008689:Methacrylates; D011945:Receptors, Angiotensin; D013777:Tetrazoles; C502776:poly(methacrylic acid-ethylene glycol dimethacrylate); D000804:Angiotensin II; D000077405:Irbesartan; D019808:Losartan; D000077333:Telmisartan